---
title: Nucleus RadioPharma July '25 Webinar
description: Learn how to navigate the CMC journey in radiopharma—from early R&D to IND submission—with experts from Nucleus and Facet Life Sciences.
image: https://info.nucleusrad.com/hubfs/header-nucleus-2%20(1)-1.jpg
---

![Nucleus RadioPharma](https://info.nucleusrad.com/hs-fs/hubfs/header-nucleus-2%20(1)-1.jpg?width=1200&height=400&name=header-nucleus-2%20(1)-1.jpg "Nucleus RadioPharma")

# From Tinker to Treasure – The CMC Journey of Radiopharma

# Hosted by Nucleus RadioPharma + Facet Life Sciences

 The radiopharmaceutical landscape is evolving rapidly—and with it, the complexity of turning early-stage discoveries into FDA-ready products that scale.

Hear from experts from Nucleus RadioPharma and Facet Life Sciences for a dynamic, practical conversation that explores the journey through Chemistry, Manufacturing, and Controls (CMC) from early R&D to IND submission and commercialization.

 This webinar is for radiopharma innovators who want to avoid common missteps and better align internal strategy with external partners.

What you’ll learn:

- What to expect from your CDMO and regulatory partners at each development phase
- Why treating GMP as a “ramp” (not isolated steps) is essential for IND-readiness
- Where teams most often underestimate the complexity of CMC
- How to navigate U.S. regulatory pathways, including for global developers entering the market

**Speakers:**

- Kathy Spencer-Pike – Nucleus RadioPharma
- Chad Crookshanks – Nucleus RadioPharma
- Jamie Chambers – Facet Life Sciences

###### Gain expert insights on GMP compliance, infrastructure, and risk management in radiopharmaceutical manufacturing:

**For ongoing updates follow us on [LinkedIn](https://www.linkedin.com/company/nucleus-radiopharma/)**

@2024 Nucleus All Rights Reserved.